Evidence-Based Complementary and Alternative Medicine / 2012 / Article / Tab 3 / Review Article
Clinical Efficacy and Safety of Buyang Huanwu Decoction for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of 19 Randomized Controlled Trials Table 3 Summary of GRADE on evidences of outcomes of Bu-yang Huan-wu decoction for acute ischemic stroke.
Quality assessment Number of patients Effect Quality Importance Number of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Trial Control Relative Absolute Effective rate 17 Randomized trials Very serious No serious inconsistency No serious indirectness No serious imprecision Reporting bias 696/747 (93.2%) 535/697 (76.8%) RR 1.18 138 more per 1000 (from 92 more to 184 more) ⨁ ○○○ very lowImportant 75% 135 more per 1000 (from 90 more to 180 more) Neurological deficit scores (Modified Edinburgh–Scandinavian Stroke Scale) 9 Randomized trials Very serious No serious inconsistency No serious indirectness No serious imprecision Reporting bias 409 377 — MD 4.65 lower (6.57 to 2.72 lower) ⨁ ○○○ very lowImportant Neurological deficit scores (ESS) 1 Randomized trials Very serious No serious inconsistency No serious indirectness No serious imprecision None 33 33 — MD 7.99 higher (3.96 to 12.02 higher) ⨁ ⨁ ○○ lowImportant
